Traws Pharma (TRAW) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to $6.4 million.
- Traws Pharma's Cash & Current Investments rose 1866.91% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year increase of 1866.91%. This contributed to the annual value of $21.3 million for FY2024, which is 248.31% up from last year.
- Per Traws Pharma's latest filing, its Cash & Current Investments stood at $6.4 million for Q3 2025, which was up 1866.91% from $13.1 million recorded in Q2 2025.
- In the past 5 years, Traws Pharma's Cash & Current Investments registered a high of $59.4 million during Q3 2021, and its lowest value of $5.4 million during Q3 2024.
- Its 5-year average for Cash & Current Investments is $31.1 million, with a median of $29.7 million in 2023.
- In the last 5 years, Traws Pharma's Cash & Current Investments skyrocketed by 18946.12% in 2021 and then tumbled by 7856.92% in 2024.
- Quarter analysis of 5 years shows Traws Pharma's Cash & Current Investments stood at $55.1 million in 2021, then decreased by 29.62% to $38.8 million in 2022, then crashed by 46.28% to $20.8 million in 2023, then grew by 2.48% to $21.3 million in 2024, then tumbled by 69.91% to $6.4 million in 2025.
- Its Cash & Current Investments stands at $6.4 million for Q3 2025, versus $13.1 million for Q2 2025 and $15.9 million for Q1 2025.